Antidiabetic and antioxidant effect of Swietenia macrophylla seeds in experimental type 2 diabetic rats

International Journal of Diabetes in Developing Countries

Volumn 33, Issue 1, 2013, Pages 60-65

  Dutta, Moumita ^a   Biswas, Utpal Kumar ^b   Chakraborty, Runu ^a   Banerjee, Piyasa ^a   Maji, Debasish ^c   Mondal, Mohan Chandra ^b   Raychaudhuri, Utpal ^a  

^a JADAVPUR UNIVERSITY   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

^c Calcutta Diabetic and Endocrine Foundation   (India)

Author keywords

Antidiabetic; Antioxidant activity; Free Oxygen Radical Defence (FORD); Swietenia macrophylla seeds; Type 2 diabetes

Indexed keywords

EID: 84873449339     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.1007/s13410-012-0109-8     Document Type: Article

References (30)

1. Koya D, King GL. Protein kinase C: activation and the development of diabetic complications. Diabetes. 1998;47:859-66. (Pubitemid 28255657)
2. Pitozzi V, Giovannelli L, Bardini G, Rotella CM, Dolara A. Oxidative DNA damage in peripheral blood cells in type diabetes mellitus: higher vulnerability of polymorphonuclear leucocytes. Mutat Res. 2003;529:129-33. (Pubitemid 37013395)
3. Ceriello A. Oxidative stress and glycemic regulation. Metabolism. 2000;49:27-9. (Pubitemid 30091790)
4. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405-12.
5. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1-9. (Pubitemid 29019345)
6. Dewanjee S, Das AK, Sahu R, Gangopahyay M. Antidiabetic activity of Diospyros peregrine fruit: effect on hyperglycemia, hyperlipidemia and augmented oxidative stress in experimental type 2 diabetes. Food Chem Toxicol. 2009;47:2679-85.
7. Knowler WC, Conner BE, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with life style intervention or metformin. N Eng J Med. 2002;346:393-403. (Pubitemid 34437694)
8. Fontebonne A, Charles MA, Vague IJ, Bard JM, Andre P, Isnand F, Cohen JM, Motlet PG, Vague P, Safar ME, Eschoege E. The effect of metformin on the metabolic abnormalities associated with upper body fat distribution. BIGPRO Study Group. Diabetes Care. 1996;19:920-8.
9. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants. New Delhi: CSIR; 1956.
10. Bhattacharya S, Chirangeebee B. Dose-dependent effects of fenugreek composite in diabetes with dyslipidaemia. Internet J Food Saf. 2006;8:49-55.
11. Asolkar LV, Kakkar KK, Chakre OJ. Second supplement to glossary of India Medical plants with active principles. Part II & I. New Delhi: Council of Scintific & Industrial Research; 1992.
12. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine. 1995;2:137-89.
13. Prajapathi ND, Purohit SS, Sharma AK, Kumar T. A Handbook of medicinal plants-A complete source book. Agrobios; (India) Jodhpur; 2003. pp. 12.
14. Sahgal G, Ramanathan S, Sasidharan S, Mordi MN, Ismail S, Mansor SM. In vitro antioxidant and xanthine oxidase inhibitory activities of methanolic Swietenia mahagoni seed extracts. Molecules. 2009;14:4476-85.
15. Chudnoff M. Tropical timbers of the world. Agric. Handbk. Washington, DC: USDA Forest Service; 1984. p. 464.
16. Francis JK. Swietenia mahagoni Jacq: West Indies mahogany. New Orleans: USDA Forest Service, Southern Forest Experiment Station; 1991. p. 7.
17. Solomon KA, Malathi R, Ranjan SS, Narasinhari S, Netajji M. Swietenine. Acta Cryst E. 2003;59:1519-21. (Pubitemid 40650755)
18. Connolly JD, Crindle RM, Overton KH, Warnock WDC. Swietenolidee. Tetrahedron Lett. 1965;6:2937-40.
19. Chan KC, Tang TS, Toh HT. Isolation of swietenolide diacetate from Swietenia Macrophylla. Phytochemistry. 1976;15:429-30.
20. Mootoo BS, Ali A, Motilal R, Pingal R, Ramlal A. Limonoids from Swietenia Macrophylla. J Nat Prod. 1999;62:1514-7.
21. Dutta M, Raychaudhuri U, Chakraborty R, Maji D. Sub-chronic toxicity study of the seeds of Swietenia macrophylla in wister rats. Sci Cult. 2012;78:78-83.
22. Dutta M, Raychaudhuri U, Chakraborty R, Maji D. Role of diet and plants on diabetic patients -A critical appraisal. Sci Cult. 2011;77:115-22.
23. Public Health Service Policy on Human Care and Use of laboratory animals. Washington, DC: US, Department of Health and Human Dervices;1986. p. 20892. Available from: Office for Protection from Research Risks, Building 31, Room 4B09, NIII, Bethesda, MD 20892. Available from: http://grants.nih.gov/grants/ olaw/olaw.htm. [Last accessed on 24 January 2011].
24. Siddque M, Sun Y, Lin JC, Chien YW. Facilitated transdermal transport of insulin. J Pharm Sci. 1987;76:341-5. (Pubitemid 17118167)
25. Karunanayake EH, Hearse DJ, Mellows G. The synthesis of 14C streptozotocinand its distribution and excretion in rat. Biochem J. 1974;142:673-85.
26. Palmieri B, Sblendorio V. Oxidative stress tests: overview on reliability and use Part II. Eur Rev Med Pharmacol Sci. 2007;11:383-99. (Pubitemid 351233583)
27. Pavlatou MG, Papastamataki M, Apostolakou F, Papassotiriou I, Tentolouris N. FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus. Metabolism. 2009;58:1657-62.
28. Kaneto H, Nakatani Y, Miyatsuke T, Kawamori D, Matsnoka T, Matsutisa M, Kajimto Y, Hori M. Possible novel therapy for diabetes with cell-permable JNR- inhibitory peptide. Nat Med. 2004;10:1128-32. (Pubitemid 39424876)
29. Tiwari AK, Rao JM. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr Sci. 2002;83:30-8. (Pubitemid 135693173)
30. Eileen M, Bulger MD, Ronald V, Maier MD. Antioxidats in critical illness. Arch Surg. 2001;136:1201-7.